Genus PLC (LSE:GNS) Share Price

Company Profile

Business description
Genus PLC is an animal genetics company focused on improving cattle and pig populations to support sustainable food production. The company operates through two main business units: one providing bovine genetics mainly for dairy and beef cattle, and the other offering porcine genetics for pork production. It generates revenue by selling genetics, including semen and embryos, as well as through related services under multi-year royalty agreements. The company's operating segments are: Genus PIC, which derives the maximum revenue and includes the porcine sales business; Genus ABS, the bovine sales business; and Genus Research and Development. Geographically, it generates the maximum revenue from North America, and the rest from Latin America, Europe, Asia, and other regions.
Contact
Basing View
Matrix House
BasingstokeHampshireRG21 4FF
GBR
T: +44 1256347100
E: [email protected]
https://www.genusplc.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2027
Employees
3,045

Recommended

Near-term pain, long-term potential.

Dan Baker | 22 October 2026

We see the company’s momentum in its core advertising business, as well as adoption of Muse, as early signals that the firm’s AI playbook is working.

Malik Ahmed Khan, CFA | 22 October 2026

Our increased valuation comes from higher full self-driving adoption assumptions and a lower near- and medium-term capital expenditures forecast.

Seth Goldstein, CFA | 22 October 2026

Index	Last price	Change	% Change
All Ordinaries	8,905.80	11.30	-0.13%
CAC 40	7,811.26	110.42	-1.39%
DAX 40	25,371.75	273.29	-1.07%
Dow JONES (US)	52,867.98	11.89	0.02%
FTSE 100	10,725.03	27.85	-0.26%
HKSE	23,076.96	142.28	0.62%
NASDAQ	26,008.86	694.00	-2.60%
Nikkei 225	62,527.74	380.10	-0.60%
NZX 50 Index	13,733.93	12.91	-0.09%
S&P 500	7,663.43	93.74	-1.21%
S&P/ASX 200	8,795.20	2.00	0.02%
SSE Composite Index	3,641.59	16.43	-0.45%